The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine MI Yilmaz, M Saglam, K Caglar, E Cakir, A Sonmez, T Ozgurtas, A Aydin, ... American Journal of Kidney Diseases 47 (1), 42-50, 2006 | 407 | 2006 |
Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance T Dogru, A Sonmez, I Tasci, E Bozoglu, MI Yilmaz, H Genc, G Erdem, ... Diabetes research and clinical practice 76 (1), 24-29, 2007 | 376 | 2007 |
Prostate cancer and adiponectin S Goktas, MI Yilmaz, K Caglar, A Sonmez, S Kilic, S Bedir Urology 65 (6), 1168-1172, 2005 | 374 | 2005 |
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease MI Yilmaz, A Sonmez, M Saglam, H Yaman, S Kilic, E Demirkaya, ... Kidney international 78 (7), 679-685, 2010 | 239 | 2010 |
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus G Erdem, T Dogru, I Tasci, A Sonmez, S Tapan Experimental and clinical endocrinology & diabetes 116 (05), 289-292, 2008 | 213 | 2008 |
The effect of the timing of hip fracture surgery on the activity of daily living and mortality in elderly H Doruk, MR Mas, C Yıldız, A Sonmez, V Kýrdemir Archives of gerontology and geriatrics 39 (2), 179-185, 2004 | 194 | 2004 |
Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin MI Yilmaz, M Saglam, AR Qureshi, JJ Carrero, K Caglar, T Eyileten, ... Nephrology Dialysis Transplantation 23 (5), 1621-1627, 2008 | 192 | 2008 |
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease MI Yilmaz, M Saglam, JJ Carrero, AR Qureshi, K Caglar, T Eyileten, ... Nephrology dialysis transplantation 23 (3), 959-965, 2008 | 188 | 2008 |
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 186 | 2021 |
Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial MI Yilmaz, A Sonmez, M Saglam, H Yaman, S Kilic, T Eyileten, K Caglar, ... American journal of kidney diseases 59 (2), 177-185, 2012 | 182 | 2012 |
Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD JJ Carrero, J Kyriazis, A Sonmez, I Tzanakis, AR Qureshi, P Stenvinkel, ... Clinical Journal of the American Society of Nephrology 7 (2), 207-215, 2012 | 156 | 2012 |
Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome MI Yilmaz, A Sonmez, K Caglar, T Celik, M Yenicesu, T Eyileten, C Acikel, ... Nephrology 12 (2), 147-153, 2007 | 151 | 2007 |
Effect of melatonin on brain oxidative damage induced by traumatic brain injury in immature rats D Ozdemir, N Uysal, S Gonenc, O Acikgoz, A Sonmez, A Topcu, ... Physiological research 54 (6), 631, 2005 | 151 | 2005 |
ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease K Caglar, MI Yilmaz, A Sonmez, E Cakir, A Kaya, C Acikel, T Eyileten, ... Kidney international 70 (4), 781-787, 2006 | 148 | 2006 |
Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes MI Yilmaz, P Stenvinkel, A Sonmez, M Saglam, H Yaman, S Kilic, ... Nephrology dialysis transplantation 26 (11), 3537-3543, 2011 | 141 | 2011 |
Plasma apelin and ADMA Levels in patients with essential hypertension A Sonmez, G Celebi, G Erdem, S Tapan, H Genc, I Tasci, CN Ercin, ... Clinical and Experimental Hypertension 32 (3), 179-183, 2010 | 139 | 2010 |
Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease MI Yilmaz, A Sonmez, AR Qureshi, M Saglam, P Stenvinkel, H Yaman, ... Clinical Journal of the American Society of Nephrology 6 (7), 1617-1625, 2011 | 131 | 2011 |
Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes MI Yilmaz, A Sonmez, A Ortiz, M Saglam, S Kilic, T Eyileten, K Caglar, ... Clinical journal of the American Society of Nephrology 6 (4), 785-792, 2011 | 125 | 2011 |
Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease Y Solak, MI Yilmaz, A Sonmez, M Saglam, E Cakir, HU Unal, M Gok, ... Clinical and experimental nephrology 17, 532-540, 2013 | 124 | 2013 |
Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease MI Yilmaz, JJ Carrero, A Ortiz, JL Martín-Ventura, A Sonmez, M Saglam, ... Clinical journal of the American Society of Nephrology 4 (11), 1716-1723, 2009 | 121 | 2009 |